Gilead Sciences (GILD) Change in Inventory (2009 - 2026)

Gilead Sciences has reported Change in Inventory for 18 years, with the latest figure at $52.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 76.68% year-over-year to $52.0 million; the trailing twelve-month figure through Mar 2026 stood at $865.0 million (up 43.21% YoY), and the FY2025 full-year result was $1.0 billion, up 143.19% from the prior year.
• Change in Inventory for Q1 2026 stood at $52.0 million, down from $123.0 million in the prior quarter.
• The five-year high for Change in Inventory was $515.0 million in Q3 2025, with the low at -$53.0 million in Q1 2022.
• Historically, Change in Inventory has averaged $156.8 million across 5 years, with a median of $123.0 million in 2025.
• Annual changes were most pronounced in 2022 — Change in Inventory sank 176.81% — and 2023, when it soared 2925.0%.
• Gilead Sciences' Change in Inventory stood at $276.0 million in 2022, then rose by 11.23% to $307.0 million in 2023, then dropped by 26.38% to $226.0 million in 2024, then sank by 45.58% to $123.0 million in 2025, then plunged by 57.72% to $52.0 million in 2026.
• The last three Change in Inventory figures came in at $52.0 million (Q1 2026), $123.0 million (Q4 2025), and $515.0 million (Q3 2025), per Business Quant data.